SIL index, comprising stage, soluble interleukin‐2 receptor, and lactate dehydrogenase, is a useful prognostic predictor in diffuse large B‐cell lymphoma

por Tomita, Naoto, Sakai, Rika, Fujisawa, Shin, Fujimaki, Katsumichi, Taguchi, Jun, Hashimoto, Chizuko, Ogawa, Koji, Yamazaki, Etsuko, Ishigatsubo, Yoshiaki
Publicado en Cancer Sci (2012)

Changing trends in prognostic factors for patients with multiple myeloma after autologous stem cell transplantation during the immunomodulator drug/proteasome inhibitor era

por Takamatsu, Hiroyuki, Honda, Sumihisa, Miyamoto, Toshihiro, Yokoyama, Kenji, Hagiwara, Shotaro, Ito, Toshiro, Tomita, Naoto, Iida, Shinsuke, Iwasaki, Toshihiro, Sakamaki, Hisashi, Suzuki, Ritsuro, Sunami, Kazutaka
Publicado en Cancer Sci (2015)

Post-treatment PET–CT Findings may Predict the Prognosis of DLBCL with a Bulky Mass

por Takasaki, Hirotaka, Yamamoto, Wataru, Ishii, Yoshimi, Takahashi, Hiroyuki, Watanabe, Reina, Harada, Taishi, Kawasaki, Rika, Hashimoto, Chizuko, Motomura, Shigeki, Tomita, Naoto, Ishigatsubo, Yoshiaki, Sakai, Rika
Publicado en Indian J Hematol Blood Transfus (2014)

Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations

por Tomita, Naoto, Tokunaka, Mami, Nakamura, Naoya, Takeuchi, Kengo, Koike, Junki, Motomura, Shigeki, Miyamoto, Ko, Kikuchi, Ako, Hyo, Rie, Yakushijin, Yoshihiro, Masaki, Yasufumi, Fujii, Soichiro, Hayashi, Takamasa, Ishigatsubo, Yoshiaki, Miura, Ikuo
Publicado 2009

MIB‐1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy

por Yamamoto, Eri, Tomita, Naoto, Sakata, Seiji, Tsuyama, Naoko, Takeuchi, Kengo, Nakajima, Yuki, Miyashita, Kazuho, Tachibana, Takayoshi, Takasaki, Hirotaka, Tanaka, Masatsugu, Hashimoto, Chizuko, Koharazawa, Hideyuki, Fujimaki, Katsumichi, Taguchi, Jun, Harano, Hiroshi, Motomura, Shigeki, Ishigatsubo, Yoshiaki
Publicado en Cancer Sci (2013)

European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients

por Yamamoto, Eri, Fujisawa, Shin, Hagihara, Maki, Tanaka, Masatsugu, Fujimaki, Katsumichi, Kishimoto, Kumiko, Hashimoto, Chizuko, Itabashi, Megumi, Ishibashi, Daisuke, Nakajima, Yuki, Tachibana, Takayoshi, Kawasaki, Rika, Kuwabara, Hideyuki, Koharazawa, Hideyuki, Yamazaki, Etsuko, Tomita, Naoto, Sakai, Rika, Fujita, Hiroyuki, Kanamori, Heiwa, Ishigatsubo, Yoshiaki
Publicado en Cancer Sci (2014)